GLPBio

Membrane Transporter/Ion Channel

Research Areas

Products Related to Membrane Transporter/Ion Channel(2454)

  • GC79542 structure
    GC79542WO662
    CAS: 3087554-10-4
    Purity: >99.00%

    WO662 (compound I-1a) is a KCNT1 inhibitor with an IC 50 ≤ 250 nM.

  • GC79543 structure
    GC79543ShK toxin TFA
    Purity: >97.50%

    ShK toxin TFA (Stichodactyla helianthus neurotoxin TFA) is a neurotoxin.

  • GC79544 structure
    GC79544E0199
    CAS: 931928-13-1
    Purity: >99.50%

    E0199 is a novel potent dual-target K V 7/Na V modulator that activates the K V 7 channel (K V 7.2/7.3 ( EC 50 = 12.78 nM), K V 7.2 ( EC 50 = 0.50 μM), and K V 7.5 ( EC 50 = 27.14 nM) channels) while simultaneously blocks the Na V 1.7 ( IC 50 = 0.52 μM), Na V 1.8 ( IC 50 = 0.24 μM), and Na V 1.9 ( IC 50 = 0.16 μM) channels.

  • GC79545 structure
    GC79545Zastaprazan citrate
    CAS: 2936619-43-9
    Purity: >99.50%

    Zastaprazan (JP-1366) citrate is a Proton pump inhibitor and potent potassium-competitive acid blocker.

  • GC79546 structure
    GC79546MK-5661
    CAS: 2417328-24-4
    Purity: >98.00%

    MK-5661 is an orally potent Na V 1.8 voltage-gated sodium channel inhibitor with an EC 50 of 4.3 nM.

  • GC79547 structure
    GC79547Cotransin TFA
    Purity: >99.50%

    Cotransin TFA is a cyclic ester peptide and a Sec61 translocator binder with signal sequence-selective activity to inhibit co-translational protein translocation.

  • GC79548 structure
    GC79548Nav1.7-IN-19
    CAS: 3097995-73-5
    Purity: >98.50%

    Nav1.7-IN-19 is a potent, selective and orally active Nav1.7 inhibitor with an IC 50 of 0.49 μM.

  • GC79549 structure
    GC79549FJ9
    CAS: 873841-43-1
    Purity: >98.50%

    FJ9 is a NHERF1/PDZ inhibitor with human NHERF1 PDZ1 IC 50 1540 μM, NHERF1 PDZ2 IC 50 160 μM, and Frizzled-7-Dishevelled PDZ complex K i 10 μM.

  • GC79709 structure
    GC79709HK2-IN-4
    CAS: 2748366-80-3
    Purity: >99.50%

    HK2-IN-4 is a selective hexokinase 2 ( HK2 ) inhibitor with an IC 50 value of 0.79 μM and a K d value of 0.41 μM.

  • GC79710 structure
    GC79710ATX-012
    CAS: 1777792-44-5
    Purity: >98.00%

    ATX-012 is an ionizable cationic lipid for the assembly of mRNA -delivering lipid nanoparticles (LNPs).

  • GC79723 structure
    GC79723Alofropodect
    CAS: 1829530-11-1
    Purity: >98.00%

    Alofropodect is an orally active, blood-brain barrier permeable phosphodiesterase 10A ( PDE10A ) inhibitor with IC 50 values of 1 nM (Reference 1) and 35 nM (Reference 2).

  • GC79781 structure
    GC797818-Br-ADPR disodium
    Purity: >98.00%

    8-Br-ADPR disodium (8-Bromoadenosine-5'-O-diphosphoribose) is a TRPM2 inhibitor and ADPR signaling pathway antagonist.

  • GC79782 structure
    GC797824''-Oxoavermectin B1a
    CAS: 122831-73-6
    Purity: >98.00%

    4''-Oxoavermectin B1a is a potentiator targeting GABA (γ-aminobutyric acid) and glutamate-gated chloride channels with insecticidal and acaricidal activities.

  • GC80414 structure
    GC80414(S)-IDOR-1117-2520
    Purity: >99.00%

    (S)-IDOR-1117-2520 is the S-isomer of IDOR-1117-2520.

  • GC80469 structure
    GC80469ω-Hexatoxin-Hv1a TFA
    Purity: >97.00%

    ω-Hexatoxin-Hv1a (ω-ACTX-Hv1; ω-Atracotoxin-HV1) TFA is an orally active insecticidal neurotoxin containing an inhibitor cystine knot motif and a selective calcium channel inhibitor.

  • GC80470 structure
    GC80470Suzetrigine N-oxide
    CAS: 2649467-76-3
    Purity: >99.00%

    Suzetrigine N-oxide (the third compound in P57) is a derivative of Suzetrigine.

  • GC80471 structure
    GC80471JNJ 303-d 3
    Purity: >99.50%

    JNJ 303 -d 3 is the deuterium labeled JNJ 303.

  • GC80473 structure
    GC80473Pregnenolone-d 6
    Purity: >98.00%

    Pregnenolone -d 6 (3β-Hydroxy-5-pregnen-20-one-d 6 ) is the deuterium labeled Pregnenolone [1] . Pregnenolone (3β-Hydroxy-5-pregnen-20-one) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones.

  • GC80840 structure
    GC80840Arecoline-d 5 hydrobromide
    CAS: 131448-18-5
    Purity: >98.00%

    Arecoline-d 5 hydrobromide is the deuterium labeled Arecoline hydrobromide.

  • GC80842 structure
    GC80842(S)-TROX-1
    CAS: 2751591-42-9
    Purity: >99.50%

    (S)-TROX-1 is the S-enantiomer of TROX-1.

  • GC80843 structure
    GC80843Acoltremon-d 3
    Purity: >99.50%

    Acoltremon -d 3 (WS-12-d 3 ) is the deuterium labeled Acoltremon.

  • GC80845 structure
    GC80845Spironolactone-d 6 -1
    Purity: >99.00%

    Spironolactone -d 6 -1 is the deuterium labeled Spironolactone.

  • GC80865 structure
    GC80865Anandamide- 15 N
    Purity: >99.50%

    Anandamide - 15 N (AEA- 15 N) is the 15 N-labeled Anandamide.

  • GC81320 structure
    GC81320Papaveroline
    CAS: 574-77-6
    Purity: >98.00%

    Papaveroline is a Fyn tyrosine kinase inhibitor, Na +,K + -ATPase inhibitor with an IC 50 of 0.20 mM, Mg 2+ -ATPase inhibitor, K + -activated pNPPase inhibitor with an IC 50 of 1.51 mM, and apoptosis inducer [1] [2] [3] . Papaveroline binds to the active site of Fyn tyrosine kinase and forms stable interactions with pocket amino acid residues [1] . Papaveroline induces cell apoptosis, produces pycnotic and fragmented cell nuclei, and does not reduce intracellular ATP levels [3] . Papaveroline is a dopamine-derived neurotoxin candidate associated with the pathogenesis of Parkinson's disease [3] . Papaveroline can be used in the research of Alzheimer's disease and Parkinson's disease [3] .